review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0952-7915(01)00278-3 |
P698 | PubMed publication ID | 11677089 |
P2093 | author name string | Fathman CG | |
Tarner IH | |||
P2860 | cites work | Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis | Q24792053 |
Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4 | Q24792474 | ||
CTLA-4 can function as a negative regulator of T cell activation | Q28235866 | ||
T cell design for therapy in autoimmune demyelinating disease | Q33943452 | ||
Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc | Q35126621 | ||
Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis | Q36375186 | ||
A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets | Q36375424 | ||
Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects | Q36477567 | ||
Antigen presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas ligand-deficient mice | Q37175936 | ||
IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion | Q37202023 | ||
Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis | Q37522009 | ||
Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis | Q39946625 | ||
Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis | Q39946646 | ||
Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit | Q40787807 | ||
Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice | Q40823580 | ||
Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity | Q40831887 | ||
Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease | Q40892667 | ||
Gene therapy for chronic relapsing experimental allergic encephalomyelitis using cells expressing a novel soluble p75 dimeric TNF receptor | Q40897697 | ||
Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein | Q40925888 | ||
Reversal of diabetes in mice by implantation of human fibroblasts genetically engineered to release mature human insulin | Q40935576 | ||
Adenovirus-mediated gene transfer of A20 in murine islets inhibits Fas-induced apoptosis | Q43552660 | ||
Adenoviral gene therapy with catalase suppresses experimental optic neuritis | Q44093665 | ||
Mechanisms of tolerance induction by a gene-transferred peptide-IgG fusion protein expressed in B lineage cells | Q45144542 | ||
Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis | Q45739253 | ||
Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction | Q45858530 | ||
Th2 T cells expressing transgene PDGF-A serve as vectors for gene therapy in autoimmune demyelinating disease | Q45861217 | ||
Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL-4 or IL-13 ameliorates murine collagen-induced arthritis (CIA). | Q45861247 | ||
Prevention of experimental allergic encephalomyelitis by intramuscular gene transfer with cytokine-encoding plasmid vectors | Q45861828 | ||
Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy | Q45864343 | ||
Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta | Q45867388 | ||
Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts | Q45867714 | ||
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach | Q45868690 | ||
Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis | Q45870165 | ||
Bone marrow-derived cells as carriers of recombinant immunomodulatory cytokine genes to lymphoid organs | Q45870540 | ||
Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue | Q45872828 | ||
IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis | Q45873853 | ||
A gene therapy approach for treating T-cell-mediated autoimmune diseases | Q45873983 | ||
Redirection of T cell effector function in vivo and enhanced collagen-induced arthritis mediated by an IL-2R beta/IL-4R alpha chimeric cytokine receptor transgene | Q45875347 | ||
Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis | Q56905891 | ||
CTLA4IgG gene delivery prevents autoantibody production and lupus nephritis in MRL/lpr mice | Q56906450 | ||
Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer | Q64379911 | ||
Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4 | Q64380123 | ||
Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer | Q64381028 | ||
Gene therapy for rheumatoid arthritis | Q64381800 | ||
Antigen-specific T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen | Q73163243 | ||
Expression of Fas ligand improves the effect of IL-4 in collagen-induced arthritis | Q73281919 | ||
P433 | issue | 6 | |
P921 | main subject | autoimmune disease | Q8084905 |
gene therapy | Q213901 | ||
P304 | page(s) | 676-682 | |
P577 | publication date | 2001-12-01 | |
P1433 | published in | Current Opinion in Immunology | Q15752917 |
P1476 | title | Gene therapy in autoimmune disease | |
P478 | volume | 13 |
Q46620103 | Adenovirus-mediated gene delivery of interleukin-10, but not transforming growth factor beta, ameliorates the induction of Graves' hyperthyroidism in BALB/c mice |
Q45867292 | Adoptive Cellular Gene Therapy for the Treatment of Experimental Autoimmune Polychondritis Ear Disease |
Q35172114 | Adoptive cellular gene therapy of autoimmune disease |
Q35164793 | Gene transfer as a future therapy for rheumatoid arthritis |
Q45863664 | Localized expression of an anti-TNF single-chain antibody prevents development of collagen-induced arthritis |
Q31122835 | Specific modulation of the anti-DNA autoantibody-nucleic acids interaction by the high affinity RNA aptamer |
Q45861637 | Stem cells engineered to express self-antigen to treat autoimmunity |
Q33757547 | Still waiting for the end. The promise of genomics and proteomics for autoimmune diseases |
Q36433286 | Synovial fibroblasts: key players in rheumatoid arthritis |
Q40690904 | Targeting autoantigen-specific T cells and suppression of autoimmune encephalomyelitis with receptor-modified T lymphocytes |
Q34580287 | Therapeutic applications for hematopoietic stem cell gene transfer |
Q46415552 | Transgene delivery and gelonin cytotoxicity enhanced by photochemical internalization in fibroblast-like synoviocytes (FLS) from rheumatoid arthritis patients |
Search more.